About Hangzhou Hysen Pharma Co., Ltd - Agriculture Supplier in China

Hangzhou Hysen Pharma Co., Ltd is located in China and lists five active pharmaceutical ingredients in its catalogue. The company reports an active product count of five, covering Entecavir, Eflornithine, Bosentan, Lercanidipine and Fulvestrant. These items are classified under the agriculture top‑category in the supplied data, but they are chemically synthesized APIs used in human medicines. Each product is identified by its generic name without additional HS‑code information in the supplied facts. The listing reflects a focus on small‑molecule drugs that are commonly traded as bulk APIs.

The catalogue does not include any declared certifications, so verification must rely on standard industry documentation. The five products span antiviral, antiparasitic, cardiovascular and endocrine therapeutic classes, indicating a diverse formulation capability. No further company history, employee numbers or production capacity are provided in the source data. The description is limited to the concrete product names and count supplied.

Product Range and Specialties of Hangzhou Hysen Pharma Co., Ltd

The supplier’s catalogue contains the APIs Entecavir, Eflornithine, Bosentan, Lercanidipine and Fulvestrant. In the pharmaceutical API market, these compounds are typically supplied at a purity of 99.5 % or higher and are graded as API‑grade material complying with pharmacopeial specifications such as USP or EP. Entecavir is an antiviral nucleoside analogue, often supplied in 25 kg drums with moisture content below 0.1 %. Eflornithine, an antiparasitic agent, is usually offered in 10 kg bags with assay limits of 98‑102 %. Bosentan, a endothelin receptor antagonist, and Lercanidipine, a calcium‑channel blocker, are commonly provided as bulk powder with particle size distribution specifications (e.g., D90 < 150 µm). Fulvestrant, an estrogen receptor degrader, is frequently supplied in 5 kg containers with a minimum of 99 % purity and a defined polymorphic form.

Trade and Export Information - Hangzhou Hysen Pharma Co., Ltd

China is a major exporter of pharmaceutical APIs, and shipments are generally classified under HS Chapter 30, especially heading 3004 for medicaments. Exporters of the listed APIs often serve markets in the United States, European Union, and Japan, where regulatory bodies such as the FDA, EMA and PMDA require GMP compliance and batch documentation. Typical certifications requested by importers include WHO‑GMP, ISO 9001 and product‑specific certificates of analysis. Bulk API shipments are usually packed in moisture‑controlled drums or poly‑bags, sealed in 20 ft or 40 ft containers, and transported under CIF or FOB terms. Customs inspections frequently verify HS codes, origin certificates and compliance with controlled substance regulations where applicable.

Sourcing from Hangzhou Hysen Pharma Co., Ltd - Buyer Guidance

Buyers should request a current Certificate of Analysis for each API, including assay, impurity profile, residual solvents and microbial limits. Verification of the supplier’s GMP status, preferably through a recent WHO‑GMP or ISO 9001 audit report, is standard practice before placing a purchase order. It is advisable to obtain a sample batch for in‑house testing and to confirm that the material meets the required pharmacopeial monograph specifications. Buyers should also confirm packaging details, such as drum linings and moisture barrier, and ensure that the shipment will be accompanied by a full commercial invoice, packing list and certificate of origin.

What pharmaceutical active ingredients does Hangzhou Hysen Pharma list?

The catalogue includes Entecavir, Eflornithine, Bosentan, Lercanidipine and Fulvestrant, each identified by generic name only.

How many different products are available from this supplier?

Five distinct API products are listed in the supplied data.

Which certifications should a buyer request from this supplier?

Buyers typically request a current GMP certificate (e.g., WHO‑GMP or ISO 9001), a Certificate of Analysis and an export certificate of origin.

What are the typical purity specifications for these APIs?

Industry standards usually require API‑grade purity of 99.5 % or higher, with assay limits defined by the relevant pharmacopeia.

What is a common minimum order quantity for bulk APIs from China?

Many Chinese API exporters set a minimum order of 1 kg to 5 kg per batch, depending on the compound and packaging format.

What packaging formats are normally used for these drugs?

Bulk APIs are commonly packed in moisture‑controlled steel drums (10‑25 kg) or high‑density polyethylene bags, sealed inside wooden crates for container loading.

Which HS code chapter is typically applied to these pharmaceutical ingredients?

Exports of bulk pharmaceutical ingredients are usually classified under HS Chapter 30, heading 3004 for medicaments.

What lead time should a buyer expect for a first shipment?

First‑time orders often require 4‑8 weeks for production, quality testing and export documentation, although exact timing depends on the specific API and regulatory approvals.